Favorable impact of FFRCT on myocardial revascularization outcomes: results from an observational real-world registry

被引：0
|
作者：
Motoc, A. [1 ]
Lammens, J. [1 ]
De Potter, T. [1 ]
Tanaka, K. [1 ]
Belsack, D. [1 ]
Vandeloo, B. [1 ]
Lochy, S. [1 ]
Michiels, V [1 ]
Tsugu, T. [1 ]
Van Dalem, A. [1 ]
Thorrez, Y. [1 ]
Magne, J. [2 ]
De Mey, J. [1 ]
Cosyns, B. [1 ]
Argacha, J. F. [1 ]
机构：
[1] Univ Hosp UZ Brussels, Brussels, Belgium
[2] Dupuytren Univ Hosp Ctr Limoges, Limoges, France
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Favorable impact of FFRCT on myocardial revascularization outcomes: results from an observational real-world registry
    Motoc, A.
    Lammens, J.
    De Potter, T.
    Tanaka, K.
    Belsack, D.
    Vandeloo, B.
    Lochy, S.
    Michiels, V
    Tsugu, T.
    Van Dalem, A.
    Thorrez, Y.
    Magne, J.
    De Mey, J.
    Cosyns, B.
    Argacha, J. F.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [2] The impact of FFRCT on clinical outcomes after myocardial revascularization
    Lammens, Johanna
    Motoc, Andreea
    Vandeloo, Bert
    Tanaka, Kaoru
    Belsack, Dries
    Michiels, Vincent
    Lochy, Stijn
    Cosyns, Bernard
    Argacha, Jean-Francois
    ACTA CARDIOLOGICA, 2024, 79 : 14 - 15
  • [3] Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
    Bressler, Adam M.
    Hassoun, Ali A.
    Saravolatz, Louis D.
    Ravenna, Valerie
    Barnes, Chris N.
    Castaneda-Ruiz, Bibiana
    DRUGS-REAL WORLD OUTCOMES, 2019, 6 (04) : 183 - 191
  • [4] Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
    Adam M. Bressler
    Ali A. Hassoun
    Louis D. Saravolatz
    Valerie Ravenna
    Chris N. Barnes
    Bibiana Castaneda-Ruiz
    Drugs - Real World Outcomes, 2019, 6 : 183 - 191
  • [5] Design and Rationale for a Real-World Prospective, Multicenter Registry of Myocardial Revascularization Failure and Secondary Revascularization: The REVASEC Study
    Salinas, Pablo
    Paul Vilchez-Tschischke, Jean
    Noriega, Francisco
    Macaya, Fernando
    Rosillo, Sandra
    Garcia-Camarero, Tamara
    Maria de la Torre-Hernandez, Jose
    de Tapia, Beatriz
    Jimenez-Kockar, Marcelo
    Regueiro, Ander
    Flores-Umanzor, Eduardo
    Garcia-Blas, Sergio
    Gonzalez-D'Gregorio, Jessika
    Gomez-Menchero, Antonio E.
    Diaz-Fernandez, Jose F.
    Rondan, Juan
    Amat-Santos, Ignacio
    Ojeda, Soledad
    Luis Diez-Gil, Jose
    de Miguel Castro, Antonio
    Lozano Ruiz-Poveda, Fernando
    Fernandez-Diaz, Jose A.
    Manzano, Maria C.
    Cruz-Gonzalez, Ignacio
    Tejerina, Virginia Pascual
    Garcia Perez-Velasco, Javier
    Serra, Antonio
    Luis Poveda-Andres, Jose
    Macaya, Carlos
    Escaned, Javier
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2022, 40 : 50 - 56
  • [6] Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry
    Millan-Iturbe, Oscar
    Sawaya, Fadi J.
    Lonborg, Jacob
    Chow, Danny H. F.
    Bieliauskas, Gintautas
    Engstrom, Thomas
    Sondergaard, Lars
    De Backer, Ole
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (04) : 818 - 826
  • [7] Real-World Clinical Use and Outcomes of Telavancin for the Treatment of Bone and Joint Infections: Results from the Telavancin Observational Use Registry (TOUR™)
    Charles R. Sims
    Adam M. Bressler
    Donald R. Graham
    Melinda K. Lacy
    David A. Lombardi
    Bibiana Castaneda-Ruiz
    Drugs - Real World Outcomes, 2021, 8 : 509 - 518
  • [8] Real-World Clinical Use and Outcomes of Telavancin for the Treatment of Bone and Joint Infections: Results from the Telavancin Observational Use Registry (TOUR™)
    Sims, Charles R.
    Bressler, Adam M.
    Graham, Donald R.
    Lacy, Melinda K.
    Lombardi, David A.
    Castaneda-Ruiz, Bibiana
    DRUGS-REAL WORLD OUTCOMES, 2021, 8 (04) : 509 - 518
  • [9] Real-world outcomes and drug survival of brodalumab: results from the German Psoriasis Registry PsoBest
    Schaeffer, Lisa
    Ben-Anaya, Nesrine
    Sorbe, Christina
    Rustenbach, Stephan Jeff
    Mrowietz, Ulrich
    Augustin, Matthias
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [10] The Effect of Renal Impairment on Outcomes from the Real-World EFive Registry
    Rothman, Martin T.
    Meredith, Ian T.
    Sinha, Nakul
    Chandra, Praveen
    Herrera, Antonio Merchan
    Lotan, Chaim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A83 - A83
12345